{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:46:57Z","timestamp":1790423217265,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Therapeutic drug monitoring (TDM) helps optimize pharmacotherapy, but research activity in low- and middle-income countries (LMICs) is poorly characterized. This scoping review systematically maps the volume, characteristics, and geographic distribution of TDM research in LMICs from 2015 to 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>PubMed, Embase, and Web of Science were searched to identify peer-reviewed TDM studies conducted in World Bank-defined LMICs. Extracted data covered publication characteristics, study design, geographic distribution, drug classes, analytical methods, and descriptive quality indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 385 publications from 38 LMICs were included; annual output steadily increased from 29 publications in 2015 to 53 in 2024. The Western Pacific Region accounted for 54.5% of all publications, with China contributing 197 (51.2%). Antimicrobials, immunosuppressants, antiseizure drugs, and antipsychotics accounted for 95.5% of drug-class attributions. Vancomycin (n = 84) and tacrolimus (n = 81) were the most studied drugs. Immunoassay was the predominant analytical method (35.1%), followed by liquid chromatography\u2013mass spectrometry (18.7%). Pharmacy and clinical pharmacology departments were involved in 47.0% of studies. Only 6 low-income countries contributed publications (n = 7) through collaborations with high-income countries (10.4%). The analytical method did not align with the country's income. Pharmacogenetic studies (n = 45), guidelines (n = 2), and external quality assessment studies (n = 2) were rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>TDM research in LMICs has expanded substantially but remains geographically concentrated and focused on drugs with commercial assays. Key gaps remain in pharmacogenetics, implementation science, and guideline development. Strengthening laboratory infrastructure, equitable international collaboration, and locally adapted TDM strategies may help advance precision medicine in resource-limited settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001505","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:00:08Z","timestamp":1784163608000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015\u20132024)"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-3717","authenticated-orcid":false,"given":"Ronaldo","family":"Morales Junior","sequence":"first","affiliation":[{"name":"Hospital S\u00edrio-Liban\u00eas, S\u00e3o Paulo, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o P.","family":"Telles","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, AC Camargo Cancer Center, S\u00e3o Paulo, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie G. S.","family":"Chua","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, Singapore General Hospital, Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142 K.","family":"Kunicki","sequence":"additional","affiliation":[{"name":"Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Medical University of Warsaw, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelia","family":"Noceti","sequence":"additional","affiliation":[{"name":"National Center for Liver Transplantation and Liver Diseases, Army Forces Hospital, Montevideo , Uruguay;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Boujaafar","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Hospital-University Sahloul, Sousse, Tunisia;"},{"name":"Faculty of Pharmacy, University of Monastir, Monastir, Tunisia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Stojanova","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Changxing People's Hospital, Changxing, China;"},{"name":"Key Laboratory of Intelligent Pharmacy and Individualized Therapy of Huzhou, Changxing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Pattanaik","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9457-8262","authenticated-orcid":false,"given":"Indy","family":"Sandaradura","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, Australia;"},{"name":"University of Sydney, Sydney, Australia; and"},{"name":"Pacific Region Infectious Diseases Association, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"R1-20260730","doi-asserted-by":"crossref","first-page":"124996","DOI":"10.1016\/j.talanta.2023.124996","article-title":"Overview of therapeutic drug monitoring and clinical practice","volume":"266","author":"Fang","year":"2024","journal-title":"Talanta"},{"key":"R2-20260730","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.mpaic.2022.05.004","article-title":"Challenges in healthcare delivery in low- and middle-income countries","volume":"23","author":"Phelan","year":"2022","journal-title":"Anaesth Intensive Care Med."},{"key":"R3-20260730","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12939-025-02526-y","article-title":"Health inequities: a persistent global challenge from past to future","volume":"24","author":"Rad","year":"2025","journal-title":"Int J Equity Health."},{"key":"R4-20260730","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jadohealth.2020.12.135","article-title":"Assessing barriers to effective coverage of health services for adolescents in Low- and middle-income countries: a scoping review","volume":"69","author":"Stierman","year":"2021","journal-title":"J Adolesc Health."},{"key":"R5-20260730","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med."},{"key":"R8-20260730","doi-asserted-by":"crossref","first-page":"dyaf058","DOI":"10.1093\/ije\/dyaf058","article-title":"How COVID-19 affected academic publishing: a 3-year study of 17 million research papers","volume":"54","author":"Whitaker","year":"2025","journal-title":"Int J Epidemiol."},{"key":"R9-20260730","article-title":"Critical care research in low- and middle-income countries: a narrative review","author":"Salluh J","year":"2025","journal-title":"Thorax"},{"key":"R10-20260730","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s00134-024-07553-x","article-title":"Examining inequality in scientific production: a focus on critical care publications and global economic disparities","volume":"50","author":"Daltro-Oliveira","year":"2024","journal-title":"Intensive Care Med."},{"key":"R11-20260730","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12913-018-3518-7","article-title":"Research capacity building frameworks for allied health professionals - a systematic review","volume":"18","author":"Matus","year":"2018","journal-title":"BMC Health Serv Res."},{"key":"R12-20260730","doi-asserted-by":"crossref","first-page":"107192","DOI":"10.1016\/j.ijantimicag.2024.107192","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients \u2013 an international perspective on access, utilisation, and barriers","volume":"64","author":"Williams","year":"2024","journal-title":"Int J Antimicrob Agents."},{"key":"R13-20260730","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(18)30308-8","article-title":"Laboratory medicine in low-income and middle-income countries: progress and challenges","volume":"391","author":"Nkengasong","year":"2018","journal-title":"Lancet"},{"key":"R14-20260730","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12913-020-05979-9","article-title":"Public-private partnerships in primary health care: a scoping review","volume":"21","author":"Joudyian","year":"2021","journal-title":"BMC Health Serv Res."},{"key":"R15-20260730","doi-asserted-by":"crossref","first-page":"92","DOI":"10.12688\/wellcomeopenres.16749.1","article-title":"Therapeutic monitoring of anti-seizure medications in low- and middle-income countries: a systematic review","volume":"6","author":"Odhiambo","year":"2021","journal-title":"Wellcome Open Res."},{"key":"R17-20260730","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00439-021-02260-9","article-title":"Pharmacogenetics in developing countries and low resource environments","volume":"141","author":"El Shamieh","year":"2022","journal-title":"Hum Genet."},{"key":"R18-20260730","first-page":"19","article-title":"Pharmacogenomics tools for precision public health and lessons for Low- and middle-income countries: a scoping review","volume":"18","author":"Borb\u00f3n","year":"2025","journal-title":"Pharmacogenomics Pers Med."},{"key":"R19-20260730","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.2147\/JMDH.S458564","article-title":"One step ahead in realizing pharmacogenetics in Low- and middle-income countries: what should we do?","volume":"17","author":"Ausi","year":"2024","journal-title":"J Multidiscip Healthc."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:01:30Z","timestamp":1785405690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":16,"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001505","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"2026-04-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}